Mass-tort marketing at $400 CPL with a 2% sign rate is a math problem, not a lead-gen strategy. The issue isn't ad spend - it's that most lead networks treat mass tort claimants as slightly more expensive personal injury leads. They aren't. A Roundup claimant with a qualifying NHL diagnosis, documented Roundup exposure pre-2020, and a filing window still open in the Ninth Circuit is a fundamentally different intake than a slip-and-fall. Routing them identically loses the case before the firm answers the phone.
Last10Legal's cohort engine pre-qualifies each intake on four dimensions: tort type, exposure window, jurisdiction (MDL certification or state court), and current MDL status. You unlock a lead that already passed those filters - not one that needs 20 minutes of phone screening to determine it's 10 years outside the statute. This guide explains how mass tort lead gen works, what separates cohort-routed leads from shared-network scraps, and the specific questions to ask any platform before you sign up.
This is not legal advice. For guidance specific to your firm's intake compliance, consult a licensed attorney in your state.
What Mass Tort Leads Actually Are (And Aren't)
A mass tort lead is a prospective claimant who believes they were harmed by a defective product or dangerous drug - and who has made affirmative contact seeking legal representation. The word "prospective" matters. Raw traffic driven by awareness ads (Facebook video views, YouTube pre-rolls, Google Display) is not a lead. Someone who filled out a form, answered qualification questions, and consented to contact is a lead.
The distinction collapses in practice because most lead aggregators blur the two. They buy top-of-funnel intent data - ad clicks, landing page visits, form starts - and sell it as intake-ready leads. The result: you're calling people who clicked a Facebook ad about Roundup cancer but haven't connected their diagnosis to Roundup use, don't know their exposure window, and are still on their first call with the firm. That's not a lead. That's a prospecting call masquerading as a referral.
What a qualified mass tort lead looks like:
- ·Confirmed tort-specific exposure (Roundup use documented; AFFF exposure at a named base; Paraquat application on a farm with dates)
- ·Qualifying diagnosis (NHL for Roundup; certain cancers for AFFF/PFAS; Parkinson's for Paraquat)
- ·Exposure window consistent with current MDL eligibility criteria
- ·Filing window still open under applicable state statute of limitations (or under the PACT Act for Camp Lejeune)
- ·Signed consent to contact - TCPA compliant
- ·No prior attorney of record
Most networks deliver two or three of these. Last10Legal's cohort engine requires all six before the lead enters your queue.
The Three Ways Firms Buy Mass Tort Leads (And Their Failure Modes)
1. Shared lead aggregators
Platforms like LeadingResponse and similar volume aggregators run national advertising campaigns across Facebook, Google, and programmatic channels, then sell the resulting form fills to multiple firms simultaneously. The selling point: volume and low per-lead price. The failure mode: shared leads on a mass tort MDL can sit in the queue 2-4 hours before a firm calls. By that time the lead has already spoken to two other attorneys. A shared lead at $150 that converts at 1% costs $15,000 per signed case - not cheap.
2. Retainer agencies (brand-spend model)
Agencies run campaigns under the firm's brand, paying Google and Meta directly. The upside: the lead belongs to the firm. The downside: MDL-specific campaigns require creative and targeting expertise to build. At peak MDL velocity (Camp Lejeune 2021-2022, AFFF 2022-2023), CPL on national Facebook campaigns ran $200-450 per form fill before qualification. When the MDL slows or the algorithm shifts, spend burns with nothing to show.
3. Pay-per-unlock with cohort routing
This is Last10Legal's model. The firm loads credits. When a pre-screened intake matching the firm's tort, jurisdiction, and urgency tier hits the system, you receive an alert. You unlock the lead by spending one credit - a fixed, attributable cost. The lead has already passed cohort filters. If the lead disconnects before first contact, the credit refunds automatically.
The math works differently. If a cohort-routed lead converts at 8-12% versus a shared lead converting at 1-2%, and the cohort-routed credit costs $300 versus $150 for a shared lead, the cost per signed case is $2,500-3,750 versus $7,500-15,000. The more expensive lead is cheaper to close.
The Cohort Engine: How Last10Legal Matches Tort-Specific Leads
The core differentiation is the cohort routing layer. Here's what it does:
Tort tagging. Every intake is tagged to a specific tort at form entry - not just 'mass tort' but 'Roundup' or 'Camp Lejeune' or 'AFFF' or 'Hair Relaxer'. This drives everything downstream. A Roundup cohort lead goes to firms certified in MDL 2741 (N.D. Cal.); an AFFF lead routes to firms with AFFF retainer agreements in MDL 2873 (D.S.C.).
Exposure window matching. Each tort has a documented exposure window tied to the litigation's eligibility criteria. AFFF: exposure at a military base or airport with documented PFAS contamination. Roundup: use prior to 2020 in most circumstances. Hair relaxer: regular use for at least a year with a qualifying uterine/endometrial cancer diagnosis. The cohort engine checks the claimant's reported exposure dates against the current MDL eligibility standard before the lead surfaces in your queue.
Jurisdiction routing. Some torts route exclusively to federal MDL court. Others (Zantac, after the MDL dismissal) route to state courts with active litigation - which varies by state bar certification and forum. Last10Legal routes each intake to firms certified in the appropriate forum, not just the highest-bidding firm.
MDL status check. Live MDL status matters. When Camp Lejeune filings were at peak velocity under the PACT Act's 2-year window (which closed August 10, 2024), routing urgency was maximum. For torts where the MDL has quieted pending bellwether trials (Paraquat MDL 3004 in S.D. Ill., Suboxone MDL 3092 in N.D. Ohio), the lead queue prioritizes claimants with fresh diagnoses over aged leads recirculated from other networks.
This is a structured intake question set mapped to eligibility criteria per active MDL. The result is a lead where the firm's first call is a conversation about representation terms, not a 20-question eligibility screen.
Compliance Requirements for Mass Tort Lead Gen
Mass tort lead generation sits at the intersection of three compliance frameworks: TCPA, state bar advertising rules, and MDL court ethics rules. Firms that buy leads without understanding all three create bar-complaint exposure.
TCPA compliance. Any SMS or phone call to a potential claimant requires prior express written consent under TCPA, with the consent disclosure on the same page as the form submission. The FCC's 2024 one-to-one consent rule (effective January 2025) means aggregators can no longer obtain a single blanket consent and sell it to multiple buyers. Each firm that intends to contact a lead must be individually named in the consent disclosure. Networks that haven't updated their consent language to the 2024 standard are selling you TCPA liability.
State bar advertising rules. New York requires the 'Attorney Advertising' label in all legal marketing materials under NY DR 2-101. Texas prohibits attorney-initiated contact (barratry) - any lead that results from the firm reaching out first, rather than a consumer-initiated contact, creates bar exposure. Florida's 30-day waiting period on direct contact after a personal injury event applies to some mass tort firms. Louisiana and Nevada require state bar pre-approval for certain advertising.
Last10Legal's compliance matrix flags each intake by state and audience type. FL and TX leads come with the relevant rules annotated. NY leads carry the required advertising disclosure. Leads from states requiring pre-approval are held in a separate queue until clearance is confirmed.
MDL ethics rules. MDL courts increasingly scrutinize mass tort marketing. Several MDL judges have issued standing orders about how claimants are solicited and screened. Ask any network you work with whether they have reviewed the standing orders in MDL 2741, MDL 2873, MDL 3004, and MDL 3092 specifically.
See also: Lead Gen Compliance for Attorneys for a full state-by-state breakdown of bar advertising rules.
Per-Tort Pricing and Volume Expectations (2026 Benchmarks)
Mass tort lead pricing varies by tort maturity, conversion complexity, and geographic distribution. These are ranges based on network-observed data.
The 3M Earplugs row illustrates the lifecycle pattern: as an MDL settles, CPL falls and lead quality declines because the straightforward cases were filed first. Firms buying 3M earplug leads now should have low expectations. Firms building pipeline on emerging torts (PFAS municipal water, social media harm MDL 3047) face the opposite dynamic: CPL is rising but conversion should be stronger as eligibility criteria clarify.
These ranges reflect network-observed data and vary by firm conversion rate and case acceptance criteria. Consult your tort lead vendor for current pricing.
What to Ask Before Signing Up With Any Mass Tort Lead Network
Seven questions that separate legitimate cohort-routing platforms from shared-lead networks dressed up in compliance language:
1. Is the consent language TCPA-compliant under the 2024 one-to-one consent rule? If the network can't produce their consent disclosure language on request, that's a red flag. If the consent form names multiple buyers, you're buying shared TCPA risk.
2. How is the lead's exposure window verified? A Roundup lead where the claimant 'can't remember' when they used it is worth much less than one with documented repeated use pre-2020. Ask whether the intake form includes specific exposure date questions and how inconsistent responses are handled.
3. What's the sharing policy? First-click-wins or batch distribution? First-click-wins means the first firm to unlock the lead gets exclusive contact rights for a defined window. Batch distribution means the lead goes to multiple firms simultaneously. These produce completely different call-back dynamics.
4. What's the exclusivity window? Last10Legal's is 5 minutes from the unlock notification. Know what you're buying and whether the window is long enough to make a real call.
5. What happens to credits on disconnected numbers or non-qualifying claimants? A refund policy on bad contacts separates platforms that stand behind their lead quality from ones that treat every click as a final sale. Last10Legal credits back automatically on disconnected numbers.
6. Which MDL court orders have you reviewed for each active tort? MDL standing orders can restrict how claimants are solicited. Any serious platform tracks these per tort.
7. How do you handle state-specific bar rules (FL 30-day, TX barratry, NY ad label)? The answer should be 'we flag it at intake and hold the lead pending clearance.' Not 'that's the firm's problem.'
Related: Personal Injury Lead Gen Guide - pay-per-lead model explained for PI firms.
How Last10Legal's Mass Tort Intake Works
The intake path for mass tort claimants at Last10Legal is purpose-built for the pre-qualification problem.
Claimants reach intake pages through organic search (tort-specific landing pages by tort and state), paid search (claimant-initiated, not solicited), and direct referral traffic. Each intake page asks tort-specific questions before collecting contact information - in the correct order, because a claimant who doesn't qualify on the exposure window shouldn't be in the funnel at all.
Once a claimant clears the eligibility questions and provides TCPA-compliant consent, they enter the cohort matching layer. The system checks: tort tag, exposure window, jurisdiction, current MDL status, and state bar compliance flags. A lead that passes all checks enters the firm queue. A lead that triggers a bar compliance flag enters a pending queue with the flag annotated.
Firm notifications come via the partner portal dashboard, SMS, and Slack webhook (configurable). The unlock interface shows the tort tag, jurisdiction, urgency tier, and compliance notes before you spend the credit. You're not buying blind.
Post-unlock, Last10Legal provides a masked Twilio number for the initial call - firm-side privacy, lead-side trust. The attribution chain from credit unlock to case sign is fully trackable. For firms managing multiple active MDLs, the partner portal allows separate tort queues with distinct credit pools and notification settings.
Apply for partner access at Last10Legal to get qualified mass tort leads in your state: Last10Legal Partner Onboarding.